Clinical effectiveness and safety of leflunomide in inflammatory arthritis: a report from the RAPPORT database with supporting patient survey.

about

Clinical effectiveness and safety of leflunomide in inflammatory arthritis: a report from the RAPPORT database with supporting patient survey.

Item

http://www.wikidata.org/entity/Q38760596

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Clinical effectiveness and saf ...... ith supporting patient survey.

@en

type

Item

label

Clinical effectiveness and saf ...... ith supporting patient survey.

@en

prefLabel

Clinical effectiveness and saf ...... ith supporting patient survey.

@en

P1476

Clinical effectiveness and saf ...... ith supporting patient survey.

@en

P2093

Dean T Eurich

http://www.w3.org/2001/XMLSchema#string

Jill J Hall

http://www.w3.org/2001/XMLSchema#string

Morgan Schultz

http://www.w3.org/2001/XMLSchema#string

Stephanie O Keeling

http://www.w3.org/2001/XMLSchema#string

Steven J Katz

http://www.w3.org/2001/XMLSchema#string

Walter P Maksymowych

http://www.w3.org/2001/XMLSchema#string

P2860

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis.

Leflunomide for treating rheumatoid arthritis.

Leflunomide use during the first 33 months after food and drug administration approval: experience with a national cohort of 3,325 patients.

Step-up combination versus switching of non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a retrospective observational study.

Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis.

Changes in use of disease-modifying antirheumatic drugs for rheumatoid arthritis in the United States during 1983-2009.

Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.

Cost effectiveness analysis of disease-modifying antirheumatic drugs in rheumatoid arthritis. A systematic review literature.

Health economic modelling of treatment sequences for rheumatoid arthritis: a systematic review.

P304

1471-1478

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10067-017-3687-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28550389

http://www.w3.org/2001/XMLSchema#string